NHLBI DNA Re-sequencing and Genotyping Program -- Genotyping Center
$968,627N01FY2009HLNIH
Johns Hopkins University, Baltimore MD
Investigators
Abstract
The overall objective of the National Heart, Lung, and Blood Institute (NHLBI) DNA Re-sequencing and Genotyping (RS &G) Program is to obtain eliable, rapid, and cost-efficient DNA re-sequencing and genotyping of candidate genomic regions potentially important in the disease pathways of heart, lung, blood, and sleep disorders. This re-sequencing and genotyping information will assist ongoing investigations of the genetic components involved in the cause, variable outcome, and progression of heart, lung, blood, and sleep diseases and disorders.
View original record on NIH RePORTER →